Does LOMITAPIDE Cause Low density lipoprotein increased? 164 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 164 reports of Low density lipoprotein increased have been filed in association with LOMITAPIDE (Juxtapid). This represents 4.3% of all adverse event reports for LOMITAPIDE.
164
Reports of Low density lipoprotein increased with LOMITAPIDE
4.3%
of all LOMITAPIDE reports
1
Deaths
13
Hospitalizations
How Dangerous Is Low density lipoprotein increased From LOMITAPIDE?
Of the 164 reports, 1 (0.6%) resulted in death, 13 (7.9%) required hospitalization, and 2 (1.2%) were considered life-threatening.
Is Low density lipoprotein increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LOMITAPIDE. However, 164 reports have been filed with the FAERS database.
What Other Side Effects Does LOMITAPIDE Cause?
Diarrhoea (1,071)
Therapy cessation (828)
Weight decreased (828)
Nausea (567)
Abdominal pain upper (280)
Flatulence (244)
Abdominal discomfort (228)
Vomiting (211)
Off label use (206)
Fatigue (200)
What Other Drugs Cause Low density lipoprotein increased?
EVOLOCUMAB (1,024)
INCLISIRAN (423)
ALIROCUMAB (336)
ROSUVASTATIN (241)
ATORVASTATIN (217)
EZETIMIBE (217)
TOFACITINIB (135)
FINGOLIMOD (132)
SOMATROPIN (93)
LORLATINIB (78)
Which LOMITAPIDE Alternatives Have Lower Low density lipoprotein increased Risk?
LOMITAPIDE vs LOMUSTINE
LOMITAPIDE vs LONAPEGSOMATROPIN-TCGD
LOMITAPIDE vs LONCASTUXIMAB TESIRINE-LPYL
LOMITAPIDE vs LOPERAMIDE
LOMITAPIDE vs LOPINAVIR